Avan Antia
Research Subjects
Avan Antia has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- David M. Alvarado
Department of Surgery, Division of Pediatric Surgery, Washington University in St. Louis School of Medicine, 425 S Euclid Avenue, Saint Louis, MO, 63110, USA.
2 shared publications - Matthew A. Ciorba
Inflammatory Bowel Diseases Center, Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, USA
2 shared publications - Siyuan Ding
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA
2 shared publications Adrianus C.M. Boon
1 shared publicationAnahi Aviles-Gamboa
1 shared publication- Astha Joshi
Department of Medicine, Washington University School of Medicine, St Louis, USA
1 shared publication
Latest Publications
- Open Access
- 9 November 2022
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 14 (1)
Prevalence of Bourbon and Heartland viruses in field collected ticks at an environmental field station in St. Louis County, Missouri, USA
- 9 November 2022
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 14 (1)
Open AccessPrevalence of Bourbon and Heartland viruses in field collected ticks at an environmental field station in St. Louis County, Missouri, USA
- Open Access
SARS-CoV-2 Omicron BA.1 variant infection of human colon epithelial cells
Omicron B.1.1.529 became the predominant SARS-CoV-2 variant in early 2022, causing a new wave of public anxiety. Compared to the ancestral strain, Omicron has 50 mutations, with over 30 mutations in the spike protein. These differences likely underlie the changes in Omicron biology noted in other studies, including an attenuation in the lung parenchyma, compared to the ancestral SARS-CoV-2 strain and other variants, as well as a preference for endosomal entry, in place of the TMPRSS2-mediated membrane fusion pathway. This raises questions on Omicron tropism and infectivity in various target organ systems, including the gastrointestinal (GI) tract. Up to 70% of COVID-19 patients report GI symptoms, including nausea, vomiting, and diarrhea. Here, we show that in the context of donor intrinsic genetic heterogeneity, the SARS-CoV-2 Omicron variant infects human colonoids similarly, if not less effectively, than the ancestral WT (WA1) strain or the Delta variant. Additionally, we note a higher ratio of viral RNA to infectious virus titer, which may suggest that Omicron is potentially less infectious in the intestine. This study lays the foundation for further work defining mechanisms mediating intestinal infection and pathogenesis by Omicron.
Open AccessSARS-CoV-2 Omicron BA.1 variant infection of human colon epithelial cells
Omicron B.1.1.529 became the predominant SARS-CoV-2 variant in early 2022, causing a new wave of public anxiety. Compared to the ancestral strain, Omicron has 50 mutations, with over 30 mutations in the spike protein. These differences likely underlie the changes in Omicron biology noted in other studies, including an attenuation in the lung parenchyma, compared to the ancestral SARS-CoV-2 strain and other variants, as well as a preference for endosomal entry, in place of the TMPRSS2-mediated membrane fusion pathway. This raises questions on Omicron tropism and infectivity in various target organ systems, including the gastrointestinal (GI) tract. Up to 70% of COVID-19 patients report GI symptoms, including nausea, vomiting, and diarrhea. Here, we show that in the context of donor intrinsic genetic heterogeneity, the SARS-CoV-2 Omicron variant infects human colonoids similarly, if not less effectively, than the ancestral WT (WA1) strain or the Delta variant. Additionally, we note a higher ratio of viral RNA to infectious virus titer, which may suggest that Omicron is potentially less infectious in the intestine. This study lays the foundation for further work defining mechanisms mediating intestinal infection and pathogenesis by Omicron.
- Open Access
- 22 December 2021
- Published by Elsevier in Gastroenterology
WITHDRAWN: Adding Fuel to The Fire? A Role of Intraepithelial Lymphocytes in Enteric Immune Responses to SARS-CoV-2 Infection
- 22 December 2021
- Published by Elsevier in Gastroenterology
Open AccessWITHDRAWN: Adding Fuel to The Fire? A Role of Intraepithelial Lymphocytes in Enteric Immune Responses to SARS-CoV-2 Infection